BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10770117)

  • 1. Hemostatic system in early respiratory distress syndrome: reduced fibrinolytic state?
    Yurdakök M; Yiğit S
    Turk J Pediatr; 1999; 41(4):489-93. PubMed ID: 10770117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma plasminogen levels in early respiratory distress syndrome.
    Yurdakök M; Yiğit S; Gürakan B; Dündar S; Kirazli S
    Turk J Pediatr; 1996; 38(2):195-7. PubMed ID: 8701484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
    Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
    Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin activatable fibrinolysis inhibitor activity, thrombin-antithrombin complex and D-dimer levels in preterm neonates with early respiratory distress syndrome.
    Gursoy T; Tekinalp G; Yurdakok M; Ozcebe O; Korkmaz A; Gurgey A
    Am J Hematol; 2008 Jan; 83(1):50-3. PubMed ID: 17654683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
    Brus F; van Oeveren W; Okken A; Oetomo SB
    Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum cortisol levels in a relatively large and mature group of ventilated and nonventilated preterm infants with respiratory distress syndrome.
    Gunes T; Koklu E; Ozturk MA; Koklu S; Cetin N
    Am J Perinatol; 2006 Aug; 23(6):335-9. PubMed ID: 16841278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global fibrinolytic capacity in early respiratory distress syndrome: a pilot study.
    Yurdakök M; Korkmaz A; Kirazli S; Aygün C; Yigit S
    Am J Hematol; 2002 Apr; 69(4):255-7. PubMed ID: 11921019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma thrombomodulin, plasminogen activator and plasminogen activator inhibitor levels in preterm infants with or without respiratory distress syndrome.
    Yurdakök M; Yigit S
    Acta Paediatr; 1997 Sep; 86(9):1022-3. PubMed ID: 9343292
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic variables in nephrotic patients.
    Cucuianu M; Manasia M; Spînu C; Trif I; Marcuşu C; Roman S; Rus HG
    Rom J Intern Med; 1991; 29(1-2):55-64. PubMed ID: 1844391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemias and fibrinolysis.
    Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
    Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates.
    Aronis S; Platokouki H; Photopoulos S; Adamtziki E; Xanthou M
    Biol Neonate; 1998 Nov; 74(5):337-44. PubMed ID: 9742262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma thrombomodulin levels in early respiratory distress syndrome.
    Yurdakök M; Yiğit S; Aliefendioğlu D; Dündar S; Kirazli S
    Turk J Pediatr; 1998; 40(1):85-8. PubMed ID: 9673533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the plasma kallikrein-kinin system in respiratory distress syndrome.
    Saugstad OD; Buø L; Johansen HT; Røise O; Aasen AO
    Pediatr Res; 1992 Oct; 32(4):431-5. PubMed ID: 1437396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of the activity of indicators of the fibrinolytic system on assessment of the hemostatic state].
    Savchuk OM; Hamisoniia MSh; Kizim OI; Platonova TM
    Fiziol Zh (1994); 2001; 47(3):58-63. PubMed ID: 11519252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.